Cargando…

Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study

BACKGROUND: Complete avoidance of residual neuromuscular blockade (RNMB) during the postoperative period has not yet been achieved in current anesthesia practice. Evidently, compliance with NMB monitoring is persistently low, and the risk of RNMB during the perioperative period remains underestimate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domenech, Gonzalo, Kampel, Matías A., García Guzzo, María E., Novas, Delfina Sánchez, Terrasa, Sergio A., Fornari, Gustavo Garcia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686238/ https://www.ncbi.nlm.nih.gov/pubmed/31390986 http://dx.doi.org/10.1186/s12871-019-0817-4

Ejemplares similares

Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome
por: Ledowski, Thomas, et al.
Publicado: (2013)

Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study
por: Gonçalves, Pedro Marcos Silva e, et al.
Publicado: (2020)

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
por: Higashi, Michiko, et al.
Publicado: (2019)

Observational study on patterns of neuromuscular blockade reversal
por: Dubovoy, Timur, et al.
Publicado: (2016)

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review
por: Liu, Guangyu, et al.
Publicado: (2017)

Sugammadex, a Neuromuscular Blockade Reversal Agent, Causes Neuronal Apoptosis in Primary Cultures
por: Palanca, José M., et al.
Publicado: (2013)

Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors
por: Quang, Thuy Luu, et al.
Publicado: (2019)

Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings
por: Bash, Lori D., et al.
Publicado: (2021)

Residual Neuromuscular Blockade and Postoperative Pulmonary Complications: What Does the Recent Evidence Demonstrate?
por: Cammu, Guy
Publicado: (2020)

Neuromuscular blockade in the elderly patient
por: Lee, Luis A, et al.
Publicado: (2016)

Intraoperative Monitoring of Neuromuscular Blockade
por: Motamed, Cyrus
Publicado: (2023)

Quantitative Relationships between Pulmonary Function and Residual Neuromuscular Blockade
por: Fu, ShuYing, et al.
Publicado: (2018)

Predictive study of pharmacological reversal for residual neuromuscular blockade and postoperative pulmonary complications: a prospective, observational, cohort study
por: Aragón-Benedí, Cristian, et al.
Publicado: (2022)

Incidence of postoperative residual neuromuscular blockade − A multicenter, observational study in Portugal (INSPIRE 2)
por: Esteves, Simão, et al.
Publicado: (2023)

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
por: Carron, Michele, et al.
Publicado: (2017)

Asystole Following Neuromuscular Blockade Reversal in Cardiac Transplant Patients
por: Nkemngu, Njinkeng J
Publicado: (2017)

Reevaluation and update on efficacy and safety of neostigmine for reversal of neuromuscular blockade
por: Luo, Jie, et al.
Publicado: (2018)

Simulation-based training for early procedural skills acquisition in new anesthesia trainees: a prospective observational study
por: Sanchez Novas, Delfina, et al.
Publicado: (2020)

Novel drug development for neuromuscular blockade
por: Prabhakar, Amit, et al.
Publicado: (2016)

Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade
por: Thilen, Stephan R., et al.
Publicado: (2016)

Effect of ulinastatin on the rocuronium-induced neuromuscular blockade
por: Kim, Min Soo, et al.
Publicado: (2012)

Improved oxygenation after discontinuing neuromuscular blockade
por: Willson, D. F., et al.
Publicado: (1997)

Neuromuscular blockade management in the critically Ill patient
por: Renew, J. Ross, et al.
Publicado: (2020)

Neuromuscular blockade management in patients with COVID-19
por: Chaves-Cardona, Harold, et al.
Publicado: (2021)

Cardiac arrest after administration of sugammadex as neuromuscular blockade reversal agent and full recovery from anesthesia
por: Samara, Evangelia, et al.
Publicado: (2020)

Effects of neuromuscular presynaptic muscarinic M(1) receptor blockade on rocuronium‐induced neuromuscular blockade in immobilized tibialis anterior muscles
por: Kim, Yong Beom, et al.
Publicado: (2018)

At therapeutic concentration bupivacaine causes neuromuscular blockade and enhances rocuronium-induced blockade
por: Lee, Ji Hyeon, et al.
Publicado: (2012)

Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade With E-Learning: Protocol for the Multicenter Interrupted Time Series INVERT Study
por: Thomsen, Jakob Louis Demant, et al.
Publicado: (2017)

A surgeon’s assessment of inadequate neuromuscular antagonism in a case of prolonged neuromuscular blockade
por: Lamberg, James J, et al.
Publicado: (2013)

Management of Residual Neuromuscular Blockade Recovery: Age-Old Problem with a New Solution
por: Green, Michael S., et al.
Publicado: (2017)

The Effect of Neuromuscular Blockade Reversal Agents on Postoperative Pulmonary Complications in Patients undergoing Femur Fracture Repair Surgery: A Retrospective Observational Study
por: Cho, Sung-Ae, et al.
Publicado: (2023)

Abdominal compartment syndrome successfully treated with neuromuscular blockade
por: Chiles, Kris T, et al.
Publicado: (2011)

Neuromuscular Blockade Correlates with Hormones and Body Composition in Acromegaly
por: Zhang, Yu, et al.
Publicado: (2020)

Neuromuscular Blockade in the Pre- and COVID-19 ARDS Patients
por: Tsolaki, Vasiliki, et al.
Publicado: (2022)

Neuromuscular Blockade Monitoring: Having It but Knowing When Not to Trust It
por: Salvador, Sara, et al.
Publicado: (2023)

Deep sedation using propofol target-controlled infusion for gastrointestinal endoscopic procedures: a retrospective cohort study
por: García Guzzo, María E., et al.
Publicado: (2020)

Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
por: Suzuki, Manzo, et al.
Publicado: (2014)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013)

Sugammadex to Reverse Neuromuscular Blockade in a Child with a Past History of Cardiac Transplantation
por: Miller, Karen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a1bnhma26kl1i2lklgk1ojhs1g